GSTM1 and malignant colon neoplasm: AnsariNejad et al. evaluated patients with stage III/IV colon cancer undergoing FOLFOX chemotherapy with Hb ≤ 120 g/L for women and ≤130 g/L for men, SF < 30 μg/L.